AstraZeneca (AZN)

Share price graph

All market data carried by City A.M. is provided by Digital Look. Neither City A.M. nor Digital Look accept any responsibility for the data’s accuracy or usage. Data is delayed by at least 15 minutes and closing prices may not be accurate at market close time.

Price: 4752.00p Today's change: -0.46%

All market data carried by City A.M. is provided by Digital Look. Neither City A.M. nor Digital Look accept any responsibility for the data’s accuracy or usage. Data is delayed by at least 15 minutes and closing prices may not be accurate at market close time.

Price: 4752.00p 5 day change: +0.69%

All market data carried by City A.M. is provided by Digital Look. Neither City A.M. nor Digital Look accept any responsibility for the data’s accuracy or usage. Data is delayed by at least 15 minutes and closing prices may not be accurate at market close time.

Price: 4752.00p 6 month change: -1.09%

Contact details

Address: 2 Kingdom Street, London
Phone: +44 (0)20 7604 8000
Fax: +44 (0)20 7604 8151
Website: www.astrazeneca.com

Company information

A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.

The lack of progress in Brexit negotiations prevented the boss of Astrazeneca from signing a letter of support [...]

9 September 2017
Shares
4
Views
993

Shares in biopharmaceutical company Circassia jumped more than 14 per cent today after a lung drug which combats [...]

7 September 2017
Shares
3
Views
463

Pharmaceuticals giant AstraZeneca today revealed a $400m (£309m) deal with Japanese drug firm Takeda to jointly [...]

29 August 2017
Shares
5
Views
152

Astrazeneca has doubled down on its investment in the UK as the British life sciences sector prepares to be the [...]

27 August 2017
Shares
27
Views
1,726

The pay of FTSE 100 bosses fell by nearly a fifth last year on the back of growing investor pressure for restraint.  [...]

3 August 2017
Shares
35
Views
1,630

Investment and trading platform Interactive Investor has revealed its top most-traded for the month of July. [...]

2 August 2017
Shares
9
Views
1,020

Shares in pharma giant AstraZeneca rose today, after it announced Imfinzi, one of its flagship cancer drugs, had [...]

31 July 2017
Shares
5
Views
839

When defending their companies against hostile takeovers, chief executives usually resort to fairly prosaic and [...]

27 July 2017
Shares
3
Views
492

AstraZeneca shares plunged more than 15 per cent in early trading in London, causing it to become the biggest [...]

27 July 2017
Shares
3
Views
1,336

Pharmaceuticals giants AstraZeneca and GlaxoSmithKline (GSK) will report half-year results this week, and all [...]

23 July 2017
Shares
17
Views
1,370

The chief executive of pharmaceuticals giant AstraZeneca has written to staff to stifle rumours he is planning [...]

21 July 2017
Shares
3
Views
437

Shares in pharmaceutical giant AstraZeneca slid in morning trading after reports suggested its chief executive [...]

13 July 2017
Shares
10
Views
1,756

AstraZeneca today announced the sale of its migraine drug to Germany's Grunenthal. [...]

7 June 2017
Views
234

AstraZeneca today confirmed it priced a three-tranche bond offering totalling $2bn (£1.6bn) yesterday, which is [...]

6 June 2017
Shares
2
Views
313

FTSE 100 pharma giant AstraZeneca has sold the commercial rights to its Seloken heart medicines in Europe for [...]

22 May 2017
Shares
8
Views
214

Content tagged with "AstraZeneca"